Likewise, in another study among 61 patients with intermediate-to-high-risk prostate cancer, [68Ga]Ga-PSMA-11 PET-CT had a sensitivity of 67% and a specificity of 98% for detecting LNI [32]. This evidence concerns the gene FOLH1 and prostate cancer.